Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Beam Therapeutics Inc. | beam-10k_20201231.htm |
| EX-32.2 - EX-32.2 - Beam Therapeutics Inc. | beam-ex322_8.htm |
| EX-32.1 - EX-32.1 - Beam Therapeutics Inc. | beam-ex321_10.htm |
| EX-31.2 - EX-31.2 - Beam Therapeutics Inc. | beam-ex312_6.htm |
| EX-31.1 - EX-31.1 - Beam Therapeutics Inc. | beam-ex311_7.htm |
| EX-21.1 - EX-21.1 - Beam Therapeutics Inc. | beam-ex211_12.htm |
| EX-10.29 - EX-10.29 - Beam Therapeutics Inc. | beam-ex1029_409.htm |
| EX-10.26 - EX-10.26 - Beam Therapeutics Inc. | beam-ex1026_406.htm |
| EX-10.25 - EX-10.25 - Beam Therapeutics Inc. | beam-ex1025_407.htm |
| EX-10.11 - EX-10.11 - Beam Therapeutics Inc. | beam-ex1011_159.htm |
| EX-10.10 - EX-10.10 - Beam Therapeutics Inc. | beam-ex1010_868.htm |
| EX-10.8 - EX-10.8 - Beam Therapeutics Inc. | beam-ex108_867.htm |
| EX-10.6 - EX-10.6 - Beam Therapeutics Inc. | beam-ex106_866.htm |
| EX-10.5 - EX-10.5 - Beam Therapeutics Inc. | beam-ex105_865.htm |
| EX-2.1 - EX-2.1 - Beam Therapeutics Inc. | beam-ex21_408.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-236582 on Form S-8 of our report dated March 15, 2021, relating to the financial statements of Beam Therapeutics Inc. and subsidiaries appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 15, 2021